Found 0 matching trials
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO) PHASE3 This trial will evaluate the efficacy and safety of ertugliflozin monothera...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers PHASE1 The purpose of this study is to help us better understand how plasma ketone...
Show More Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Learn More & Join Trial
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study PHASE4 SGLT2 inhibitors such as ertugliflozin improve blood pressure and kidney ou...
Show More Learn More & Join Trial
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002) PHASE3 This study will evaluate the efficacy and safety of the addition of ertugli...
Show More Location
Multiple Locations
Learn More & Join Trial
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) PHASE3 This study evaluated the safety and efficacy of ertugliflozin (MK-8835) in ...
Show More Location
The University of Alabama at Birmingham ( Site 2207)
Learn More & Join Trial
A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020) PHASE1 This study will evaluate the absolute oral bioavailability (F) and fraction...
Show More Location
Multiple Locations
Learn More & Join Trial